Laxmi Dental Limited (NSE:LAXMIDENTL) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Last week saw the newest quarterly earnings release from Laxmi Dental Limited (NSE:LAXMIDENTL), an important milestone in the company's journey to build a stronger business. Results were roughly in line with estimates, with revenues of ₹723m and statutory earnings per share of ₹6.05. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

Taking into account the latest results, the current consensus from Laxmi Dental's three analysts is for revenues of ₹2.96b in 2026. This would reflect a notable 13% increase on its revenue over the past 12 months. Statutory earnings per share are predicted to shoot up 59% to ₹7.50. Before this earnings report, the analysts had been forecasting revenues of ₹3.01b and earnings per share (EPS) of ₹9.10 in 2026. The analysts seem to have become more bearish following the latest results. While there were no changes to revenue forecasts, there was a substantial drop in EPS estimates.

Check out our latest analysis for Laxmi Dental

It might be a surprise to learn that the consensus price target was broadly unchanged at ₹470, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. It could also be instructive to look at the range of analyst estimates, to evaluate how different the outlier opinions are from the mean. The most optimistic Laxmi Dental analyst has a price target of ₹510 per share, while the most pessimistic values it at ₹400. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. The analysts are definitely expecting Laxmi Dental's growth to accelerate, with the forecast 27% annualised growth to the end of 2026 ranking favourably alongside historical growth of 20% per annum over the past year. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 14% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Laxmi Dental is expected to grow much faster than its industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. The consensus price target held steady at ₹470, with the latest estimates not enough to have an impact on their price targets.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Laxmi Dental going out to 2028, and you can see them free on our platform here..

That said, it's still necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Laxmi Dental , and understanding these should be part of your investment process.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.